Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ·Healthcare·Biotechnology
$1.56
-0.32%
Mkt Cap $1.65M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 10, 2026 | — | — | — | -$2.10 | -$1.81 | +13.81% | — | — |
| Q4 2025 Nov 13, 2025 | — | — | — | -$2.25 | -$2.00 | +11.11% | — | — |
| Q3 2025 Aug 13, 2025 | — | — | — | -$0.22 | -$0.18 | +18.18% | — | — |
| Q2 2025 May 14, 2025 | — | — | — | -$0.50 | -$0.34 | +32.00% | — | — |
| Q1 2025 Mar 4, 2025 | — | — | — | -$0.38 | -$0.15 | +60.53% | — | — |
| Q4 2024 Nov 13, 2024 | — | — | — | -$0.50 | -$0.38 | +24.00% | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | -$0.39 | -$0.59 | -51.28% | — | — |
| Q2 2024 May 14, 2024 | — | — | — | -$0.51 | -$0.68 | -33.33% | — | — |
| Q2 2024 Apr 4, 2024 | — | — | — | -$0.76 | -$1.35 | -77.63% | — | — |
| Q4 2023 Nov 14, 2023 | — | — | — | -$1.14 | -$1.14 | +0.00% | — | — |
| Q3 2023 Aug 21, 2023 | — | — | — | -$1.50 | -$1.33 | +11.33% | — | — |
| Q2 2023 May 12, 2023 | — | — | — | -$3.50 | -$2.75 | +21.43% | — | — |
| Q1 2023 Mar 30, 2023 | — | — | — | -$3.75 | -$2.75 | +26.67% | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | -$4.50 | -$3.00 | +33.33% | — | — |
| Q3 2022 Aug 16, 2022 | — | — | — | -$4.00 | -$4.00 | +0.00% | — | — |
| Q2 2022 May 16, 2022 | — | — | — | -$4.25 | -$3.25 | +23.53% | — | — |
| Q1 2022 Mar 28, 2022 | — | — | — | -$0.21 | -$7.00 | -3233.33% | — | — |
| Q4 2021 Nov 15, 2021 | — | — | — | -$5.50 | -$5.50 | +0.00% | — | — |
| Q3 2021 Aug 12, 2021 | — | — | — | -$0.20 | -$6.25 | -3025.00% | — | — |
| Q2 2021 May 17, 2021 | — | — | — | — | -$7.50 | — | — | — |